Back | Next |
home / stock / cdtx / cdtx message board
Subject | By | Source | When |
---|---|---|---|
once we get over the major 2.30 than | masterbug1 | investorshub | 03/01/2023 6:26:58 PM |
that little wall is nothing. Were going to | masterbug1 | investorshub | 03/01/2023 6:20:06 PM |
It will get approve, yes 22 Buy all | masterbug1 | investorshub | 03/01/2023 6:18:18 PM |
Potential drug approval hopefully ...... around 22nd!!?? | now invest | investorshub | 03/01/2023 5:53:53 PM |
Lol good like I said were in the | masterbug1 | investorshub | 03/01/2023 5:40:42 PM |
Good luck | masterbug1 | investorshub | 03/01/2023 5:38:35 PM |
4. Should be no problem. | masterbug1 | investorshub | 03/01/2023 5:38:19 PM |
Yea.... hit 1.9199!! Not | now invest | investorshub | 03/01/2023 5:34:34 PM |
Just sold 4 options. March 17..... $2.50 for | now invest | investorshub | 03/01/2023 5:31:55 PM |
HC Wainwright maintained target at $6.50!! | now invest | investorshub | 03/01/2023 5:29:07 PM |
Like I said get to the chopper | masterbug1 | investorshub | 03/01/2023 4:52:02 PM |
yeaaa hit the 1.80 weeeeee | masterbug1 | investorshub | 03/01/2023 4:35:41 PM |
weeee Dont t get to excited Hold | masterbug1 | investorshub | 03/01/2023 4:32:26 PM |
52 week high is going to pass it | masterbug1 | investorshub | 03/01/2023 4:06:01 PM |
Agree.... and looks like we may get a | now invest | investorshub | 02/24/2023 12:39:11 PM |
lookin good. IMHO STILL A BARGAIN. | RUPHERT | investorshub | 02/07/2023 1:05:52 AM |
Nice little run.... surprised so little followers... | now invest | investorshub | 02/03/2023 4:38:34 PM |
As much as this is a sad time | DK11 | investorshub | 01/25/2023 9:15:51 PM |
znewcar1: $CDTX 37% v23M c1.28 f71,618M H1.30 ML.56 again | znewcar1 | investorshangout | 01/25/2023 9:14:32 PM |
$CDTX: Nice Close here!!! | Invest-in-America | investorshub | 01/25/2023 9:13:16 PM |
News, Short Squeeze, Breakout and More Instantly...
Cidara Therapeutics Inc. Company Name:
CDTX Stock Symbol:
NASDAQ Market:
Cidara Therapeutics Inc. Website:
NEW YORK, NY / ACCESSWIRE / May 2, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cidara Therapeutics, Inc. ("Cidara" or "the Company") (NASDAQ:CDTX). Investors who purchased Cidara securities are encouraged to obtain additional informa...
SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak&...
SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serio...